Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education.
Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.
In this episode, Diana Isaacs, PharmD, BCPS, BCACP, CDCES, BC-ADM, FADCES, FCCP, and Joshua J. Neumiller, PharmD, CDCES, FADCES, FASCP, discuss the use of mineralocorticoid receptor antagonists in patients with chronic kidney disease and type 2 diabetes, including:
Endocrine Clinical Pharmacy Specialist
CGM and Remote Monitoring Program Coordinator
Endocrinology and Metabolism Institute
Vice Chair & Allen I. White Distinguished Professor
Department of Pharmacotherapy
College of Pharmacy and Pharmaceutical Sciences
Washington State University
This program has been made available online.
Concise microlearning module featuring expert insight on challenges of traditional treatment of anemia of CKD from Clinical Care Options (CCO)
Unlocked downloadable slides featuring an overview of the challenges of traditional anemia treatment in patients with CKD, from Clinical Care Options (CCO)
Downloadable slides on osteoporosis pharmacotherapy in adults, provided by Clinical Care Options (CCO)
Concise microlearning module on osteoporosis pharmacotherapy, from Clinical Care Options (CCO)